Romiplostim for Immune Thrombocytopenia in Neuroblastoma Patients Receiving Chemotherapy.
J Pediatr Hematol Oncol. 2018 Apr 20;:
Authors: Fassel H, Bussel JB, Roberts SS, Modak S
Abstract Thrombocytopenia, a serious complication of myelosuppressive chemotherapy in cancer patients, is managed with platelet transfusions until recovery of platelet counts. However, children receiving chemotherapy can rarely develop immune thrombocytopenia (ITP) that is refractory to transfused platelets.